Education
About Us
Working with TipRanks
Follow Us
Anatara Lifesciences Ltd (AU:ANR)
ASX:ANR
ANR Stock Chart & Stats
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.07
Previous CloseN/A
Volume35.84K
Average Volume (3M)1.06M
Market Cap
AU$1.71M
Enterprise ValueAU$1.37M
Total Cash (Recent Filing)AU$1.10M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta-0.17
Next Earnings
Mar 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding213,590,330
10 Day Avg. Volume3,048,202
30 Day Avg. Volume1,062,709
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Anatara Lifesciences Ltd News
ANR FAQ
What was Anatara Lifesciences Ltd’s price range in the past 12 months?
Anatara Lifesciences Ltd lowest share price was <AU$0.01 and its highest was AU$0.07 in the past 12 months.
What is Anatara Lifesciences Ltd’s market cap?
Anatara Lifesciences Ltd’s market cap is AU$1.71M.
When is Anatara Lifesciences Ltd’s upcoming earnings report date?
Anatara Lifesciences Ltd’s upcoming earnings report date is Mar 03, 2026 which is in 177 days.
How were Anatara Lifesciences Ltd’s earnings last quarter?
Anatara Lifesciences Ltd released its earnings results on Aug 20, 2025. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.
Is Anatara Lifesciences Ltd overvalued?
According to Wall Street analysts Anatara Lifesciences Ltd’s price is currently Overvalued.
Does Anatara Lifesciences Ltd pay dividends?
Anatara Lifesciences Ltd does not currently pay dividends.
What is Anatara Lifesciences Ltd’s EPS estimate?
Anatara Lifesciences Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anatara Lifesciences Ltd have?
Anatara Lifesciences Ltd has 213,590,330 shares outstanding.
What happened to Anatara Lifesciences Ltd’s price movement after its last earnings report?
Anatara Lifesciences Ltd reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Anatara Lifesciences Ltd?
Currently, no hedge funds are holding shares in AU:ANR
Anatara Lifesciences Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:ANR Sentiment 75%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
―
20 days / 200 days
Momentum
-76.08%
12-Months-Change
Fundamentals
Return on Equity
-205.70%
Trailing 12-Months
Asset Growth
-31.29%
Trailing 12-Months
Company Description
Anatara Lifesciences Ltd
Anatara Lifesciences Ltd (ANR) is an Australian biotechnology company that operates in the life sciences sector. The company is focused on developing products for human and animal health, particularly in the areas of gastrointestinal health. Anatara's core products include therapeutic and preventative solutions for conditions such as irritable bowel syndrome (IBS) in humans and gastrointestinal diseases in animals.
Technical Analysis
AnteoTech Ltd
―
Regeneus Ltd.
―
Avecho Biotechnology Limited
―
AdAlta Ltd.
―
Hexima Ltd
―
Options Prices
Currently, No data available
---